PTX prescient therapeutics limited

Ann: OmniCAR technical issues resolved and program to progress, page-12

  1. 8,330 Posts.
    lightbulb Created with Sketch. 3661
    No, the 9-fold improvement relates to the combination of CellPryme A with CellPryme B. But, yes, OmniCAR has the promise to transform immunotherapies such as CAR technoolgy.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
5.0¢
Change
-0.001(1.96%)
Mkt cap ! $38.65M
Open High Low Value Volume
5.2¢ 5.2¢ 4.8¢ $56.20K 1.152M

Buyers (Bids)

No. Vol. Price($)
2 73659 4.7¢
 

Sellers (Offers)

Price($) Vol. No.
5.0¢ 179998 1
View Market Depth
Last trade - 15.59pm 18/06/2025 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.